The CDC's Nowcast data tracker, which displays COVID-19 estimates and projections for two-week periods, reflected that the KP.3.1.1 variant accounted for 57.2% of positive infections, followed by XEC at 10.7% in the two weeks starting on Sept. 29 and ending on Oct. 12.

The XEC variant of Covid is quickly becoming the dominant strain of the winter, but the current vaccines may not be as effective against it

Even previous versions of the vaccine built from XEC’s predecessors like omicron might not be as effective against the new mutation

The XEC Covid variant is incredibly fast spreading, and now that it's been detected in multiple countries, it's vital that everyone is aware of the symptoms to look out for - including the unusual ord

New COVID strain XEC is a recombinant strain of two variants in the Omicron family: KS.1.1 and KP.3.3. The hybrid strain was first reported in Berlin in late June but has spread across Europe, North America and Asia, with Germany, France, the Netherlands and Denmark leading the charge.

XEC is on track to become the new dominant COVID-19 strain this winter. Yale and New Haven experts weigh in on why you should still get the new vaccine even though it may be less effective at neutralization because it is a recombinant variant.

A new COVID-19 variant found by health experts in the UK has made its way to Ireland as many prepare themselves for winter, also known as flu season. Health officials have recently published an update on COVID-19 in Ireland,

Covid hospitalisations have surged across Britain at an “alarming” rate as a new variant of the virus emerged, the UK Health Security Agency (UKHSA) has warned. UKHSA figures showed the admission rate for patients testing positive for Covid XEC stood at 4.5 per 100,000 people in the week to October 6 – up from 3.7 a week earlier.